XBiotech Inc
XBIT - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$57.32M
Close$
$4.12
115.6% upside
Current Fair Value
115.6% upsideUndervalued by 115.6% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $57.32 Million |
|---|---|
| Enterprise Value | $-50,379,066.00 |
| Earnings per Share | $-1.49 |
| Beta | 0.8 |
| Outstanding Shares | 30,487,731 |
Return
| Return on Equity | -35.13% |
|---|---|
| Return on Assets | -33.77% |
| Return on Invested Capital | -35.81% |
Valuation & Multiples
| P/E Ratio | -1.27 |
|---|---|
| PEG | -0.45 |
| Price to Sales | - |
| Price to Book Ratio | 0.48 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | 1.08 |
| Enterprise Value to Net Income | 1 |
| Total Debt to Enterprise | -0.04 |
| Debt to Equity | 0.01 |
Revenue Sources
No data
Last Earnings Call
Report Date
August 13, 2026
EPS Estimate
$0.03
Consensus analyst estimateRevenue Estimate
$7.00 M
Consensus analyst estimateInstitutional Put/Call Ratio
Compares institutional put options with call options. At 0.00, the ratio is below 1, so institutions hold more calls than puts.
| Put/Call Ratio | 0.0000▼ 42.06% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | -▼ 100.00% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 0.00%▼ 6.50% |
|---|---|
| Total Invested | $31▼ 100.00% |
| Investors Holding | 1▼ 38.00% |
About XBiotech Inc
CEO: John Simard
